Skip to main content
. 2025 Aug 20;26(16):8054. doi: 10.3390/ijms26168054
1O2 singlet oxygen
ALA 5-aminolevulinic acid
AK actinic keratosis
BCC basal cell carcinoma
BD Bowen’s disease
CR complete response
DFO desferrioxamine
MAL methyl aminolevulinate
nBCC nodular basal cell carcinoma
PDT photodynamic therapy
PpIX protoporphyrin IX
PS photosensitizer(s)
RCT randomized controlled trial
ROS reactive oxygen species
sBCC superficial basal cell carcinoma